Trypanocidal activity of human plasma on Trypanosoma evansi in mice

this study aimed to test an alternative protocol with human plasma to control trypanosoma evansi infection in mice. plasma from an apparently 27-year-old healthy male, blood type a+, was used in the study. a concentration of 100 mg.dl-1 apolipoprotein l1 (apol1) was detected in the plasma. forty mice were divided into four groups with 10 animals each. group a comprised uninfected animals. mice from groups b, c and d were inoculated with a t. evansi isolate. group b was used as a positive control. at three days post-infection (dpi), the mice were administered intraperitoneally with human plasma. a single dose of 0.2 ml plasma was given to those in group c. the mice from group d were administered five doses of 0.2 ml plasma with a 24 hours interval between the doses. group b showed high increasing parasitemia that led to their death within 5 dpi. both treatments eliminated parasites from the blood and increased the longevity of animals. an efficacy of 50 (group c) and 80% (group d) of human plasma trypanocidal activity was found using pcr. this therapeutic success was likely achieved in the group d due to their higher levels of apol1 compared with group c.